CytRx Corporation (NASDAQ: CYTR) announced that a 44-year-old female patient with advanced acute promyelocytic leukemia (APL) achieved molecular complete remission ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE